Please Wait.....
Report
Europe, Asia, Middle East & Africa Medical Devices Market Research Report Forecast to 2030
Market Report I 2023-06-15 I 360 Pages I Market Research Future
Europe, Asia, Middle East & Africa Medical Devices Market Research Report Forecast to 2030
Market Overview
The countries within the scope of the study have been analyzed basis of a few factors to gather an understanding of the patient population and the countries. A Patent Foramen Ovale (PFO) is a hole in the wall between the left and right atria of every human fetus. This hole is a small flaplike opening between the upper heart chambers that allows blood to bypass the fetal lungs, which cannot work until they are exposed to air. When a newborn enters the world and takes its first breath, the foramen ovale closes, and within a few months, it has sealed completely in about 75% of cases and when in some cases it remains open, it is called a PFO. In most people treatment for PFO is not required. However, if a stroke related to the PFO is diagnosed, closure is recommended as it prevents blood clots from moving to other parts of the body such as the brain and heart, which could cause a stroke. Additionally, an Atrial septal defect (ASD) is a congenital heart defect (hole) in the inter-atrial septum that typically allows blood to go from the left to right chambers. The hole increases the amount of blood that passes through the lungs. ASD is one of the most common congenital cardiac diseases and usually affects women more than men. Hence, the rising female population suffering from ASD is driving the Atrial Septal Defect (ASD) market growth during the forecast period. In addition, the increasing prevalence of congenital heart diseases and increasing government spending on healthcare are driving the growth of the Patent Foramen Ovale (PFO) and Atrial Septal Defect (ASD) market. For instance, according to the Eurostat database, healthcare expenditure was EUR 10,73,000 million or 8.0% of GDP in 2020. Hence, rising healthcare expenditure also increases company activities and government initiatives in developing effective heart defect closure devices for the treatment of congenital heart defects to prevent recurrent ischemic stroke. These factors are anticipated to positively impact the growth of the market. Moreover, the high incidence rate for ischemic stroke is expected to augment the growth of the market over the forecast period. Stroke is one of the leading causes of death in Europe, Asia, the Middle East & Africa. Peripheral artery disease (PAD) has changed over time as the prevalence of associated risk factors and co-morbidities including the increase in insulin-dependent diabetes and the changing dynamic of tobacco use has evolved. For instance, countries such as Pakistan, Uzbekistan, Egypt, Azerbaijan, Iran, and Algeria have registered an increase in the prevalence of diabetes and is anticipated to grow in the coming years. This, in turn, will increase the demand for medical devices associated with the treatment of PAD in these countries.
Regional Analysis
Europe, Asia, Middle East & Africa Medical Devices Market is studied across various countries such as Romania, Belarus, Iran, Iraq, Serbia, Azerbaijan, Algeria, Tunisia, Morocco, Egypt, Nigeria, Kenya, Ukraine, Uzbekistan, Pakistan, and Bosnia and Herzegovina
Major Players
Boston Scientific Corporation, Medtronic Plc, B. Braun Melsungen AG, Baxter International Inc., Johnson & Johnson, Merit Medical Systems, Inc., Abbott Laboratories Inc., Becton, Dickinson and Company, CONMED Corporation, Olympus Corporation, and Koninklijke Philips N.V.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 MARKET INTRODUCTION 37
1.1 RESEARCH OBJECTIVE 37
2 DEMOGRAPHIC ANALYSIS BY COUNTRY 38
2.1 OVERVIEW 38
2.2 AGE GROUP DEMOGRAPHICS 38
2.2.1 ANALYST COMMENT 38
2.3 GROSS DOMESTIC PRODUCT (GDP) 40
2.4 HEALTHCARE SPENDING, (BILLION EURO), 2019-2021 41
2.5 STATISTICAL ANALYSIS: DISEASE WISE INCIDENCE, PREVELANCE, AND MORTALITY 41
2.5.1 ENDOVASCULAR BY DISEASE 41
2.5.1.1 ABDOMINAL AORTIC ANEURYSM (AAA) 41
2.5.1.2 THORACIC AORTIC ANEURYSM (TAA) 43
2.5.1.3 PERIPHERAL ARTERIAL DISEASE (PAD) 44
2.5.2 CARDIAC DISEASE 46
2.5.2.1 PATENT FORAMEN OVALE (PFO) 46
2.5.2.2 ATRIAL SEPTAL DEFECT (ASD) 47
2.5.3 SURGERY, BY DISEASE 49
2.5.3.1 OBESITY 49
2.5.3.2 HERNIA 50
2.6 SPENDING CAPACITY 51
2.6.1 ANALYST COMMENT 51
2.7 PATIENT KNOWLEDGE ABOUT TREATMENT OPTIONS 52
2.7.1 ANALYST COMMENT 52
2.8 LIST OF KEY HOSPITALS, BY REGION 53
2.8.1 ROMANIA 53
2.8.2 BELARUS 53
2.8.3 IRAN 54
2.8.4 IRAQ 54
2.8.5 SERBIA 55
2.8.6 AZERBAIJAN 55
2.8.7 ALGERIA 55
2.8.8 TUNISIA 56
2.8.9 MOROCCO 56
2.8.10 EGYPT 57
2.8.11 NIGERIA 59
2.8.12 KENYA 60
2.8.13 UZBEKISTAN 61
2.8.14 PAKISTAN 61
2.8.15 UKRAINE 62
2.8.16 BOSNIA AND HERZEGOVINA 62
3 MARKET FACTOR ANALYSIS COVERAGE, BY COUNTRY 63
3.1 PERIPHERAL ARTERY DISEASE: MARKET ANALYSIS 63
3.1.1 MARKET TRENDS AND REVENUE POCKETS 63
3.1.2 MARKET DRIVERS AND RESTRAINTS, BY COUNTRY 68
3.1.2.1 ROMANIA 68
3.1.2.2 BELARUS 68
3.1.2.3 IRAN 69
3.1.2.4 IRAQ 69
3.1.2.5 SERBIA 69
3.1.2.6 AZERBAIJAN 70
3.1.2.7 ALGERIA 70
3.1.2.8 TUNISIA 71
3.1.2.9 MOROCCO 71
3.1.2.10 EGYPT 71
3.1.2.11 NIGERIA 72
3.1.2.12 KENYA 72
3.1.2.13 UZBEKISTAN 72
3.1.2.14 PAKISTAN 73
3.1.2.15 UKRAINE 73
3.1.2.16 BOSNIA AND HERZEGOVINA 73
3.1.3 FUTURE POTENTIAL OPPORTUNITY POCKETS 74
3.1.3.1 INCREASING GOVERNMENT INITIATIVES 74
3.1.3.2 RISING ADOPTION OF MINIMALLY INVASIVE PROCEDURES AND COMPANY INITIATIVES 74
3.1.3.3 INCREASING ADOPTION OF UNHEATHY LIFESTYLE AND FOOD HABITS 75
3.1.4 IMPACT OF CORONAVIRUS (COVID-19) PANDEMIC ON MARKET 76
3.1.5 STATISTICAL OVERVIEW: BYPASS PROCEDURES, 2021-2022 76
3.1.6 LEG AMPUTATION 77
3.2 ABDOMINAL AORTIC ANEURYSM (AAA) AND THORACIC AORTIC ANEURYSM (TAA) 79
3.2.1 AAA AND TAA MARKET TRENDS, DRIVERS, AND RESTRAINTS 79
3.2.2 MARKET DRIVERS AND RESTRAINTS 80
3.2.2.1 ROMANIA 80
3.2.2.2 BELARUS 80
3.2.2.3 IRAN 81
3.2.2.4 IRAQ 81
3.2.2.5 SERBIA 82
3.2.2.6 AZERBAIJAN 82
3.2.2.7 ALGERIA 83
3.2.2.8 TUNISIA 83
3.2.2.9 MOROCCO 84
3.2.2.10 EGYPT 84
3.2.2.11 NIGERIA 85
3.2.2.12 KENYA 85
3.2.2.13 UZBEKISTAN 86
3.2.2.14 PAKISTAN 86
3.2.2.15 UKRAINE 87
3.2.2.16 BOSNIA AND HERZEGOVINA 87
3.2.3 AAA AND TAA MARKET OPPORTUNITIES AND REVENUE POCKETS 87
3.2.3.1 INCREASING GOVERNMENT INITIATIVES 87
3.2.3.2 INCREASING ADOPTION OF UNHEATHY LIFESTYLE AND FOOD HABITS 88
3.2.3.3 TECHNOLOGICAL ADVANCEMENTS IN AAA AND TAA TREATMENT 90
3.2.4 IMPACT OF THE CORONAVIRUS (COVID-19) PANDEMIC ON AAA AND TAA MARKET 90
3.3 PATENT FORAMEN OVALE (PFO) AND ATRIAL SEPTAL DEFECT (ASD) 91
3.3.1 MARKET TRENDS, DRIVERS, AND RESTRAINTS 91
3.3.2 MARKET DRIVERS AND RESTRAINTS 92
3.3.2.1 ROMANIA 92
3.3.2.2 BELARUS 93
3.3.2.3 IRAN 93
3.3.2.4 IRAQ 94
3.3.2.5 SERBIA 94
3.3.2.6 AZERBAIJAN 95
3.3.2.7 ALGERIA 95
3.3.2.8 TUNISIA 96
3.3.2.9 MOROCCO 96
3.3.2.10 EGYPT 97
3.3.2.11 NIGERIA 97
3.3.2.12 KENYA 98
3.3.2.13 UZBEKISTAN 98
3.3.2.14 PAKISTAN 99
3.3.2.15 UKRAINE 99
3.3.2.16 BOSNIA AND HERZEGOVINA 100
3.3.3 MARKET OPPORTUNITIES AND REVENUE POCKETS 100
3.3.3.1 GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES 100
3.3.3.2 TECHNOLOGICAL ADVANCEMENTS IN THE HEART CLOSURE DEVICE INDUSTRY 101
3.3.3.3 INCREASING GOVERNMENT INITIATIVES 101
3.3.4 IMPACT OF THE CORONAVIRUS (COVID-19) PANDEMIC ON MARKET 102
3.4 HERNIA AND BARIATRIC SURGERY 102
3.4.1 MARKET TRENDS AND REVENUE POCKETS 102
3.4.2 MARKET DRIVERS AND RESTRAINTS 105
3.4.2.1 ROMANIA 105
3.4.2.2 BELARUS 106
3.4.2.3 IRAN 106
3.4.2.4 IRAQ 107
3.4.2.5 SERBIA 107
3.4.2.6 AZERBAIJAN 108
3.4.2.7 ALGERIA 108
3.4.2.8 TUNISIA 109
3.4.2.9 MOROCCO 109
3.4.2.10 EGYPT 110
3.4.2.11 NIGERIA 110
3.4.2.12 KENYA 111
3.4.2.13 UZBEKISTAN 111
3.4.2.14 PAKISTAN 112
3.4.2.15 UKRAINE 112
3.4.2.16 BOSNIA AND HERZEGOVINA 113
3.4.3 FUTURE POTENTIAL OPPORTUNITY POCKETS 113
3.4.3.1 INCREASING GOVERNMENT INITIATIVES 113
3.4.3.2 RISING ADOPTION OF MINIMALLY INVASIVE PROCEDURES 114
3.4.3.3 INCREASING ADOPTION OF UNHEATHY LIFESTYLE AND FOOD HABITS 114
3.4.3.4 TECHNOLOGICAL ADVANCEMENTS IN BARIATRIC AND HERNIA SURGERY 115
3.4.3.5 EXPANSION OF MAJOR GLOBAL PLAYERS INTO THE DEVELOPING COUNTRIES 116
3.4.4 IMPACT OF THE CORONAVIRUS (COVID-19) PANDEMIC ON MARKET 117
4 MARKET ANALYSIS FOR ENDOVASCULAR AND CARDIAC DISEASE, BY COUNTRY 118
4.1 ABDOMINAL AORTIC ANEURYSM (AAA) 118
4.1.1 REALISTIC SCENARIO 118
4.1.2 PESSIMISTIC SCENARIO 119
4.1.3 OPTIMISTIC SCENARIO 119
4.2 EUROPE, ASIA, AND MIDDLE EAST & AFRICA ABDOMINAL AORTIC ANEURYSM: COUNTRY LEVEL ANALYSIS 122
4.2.1 ROMANIA 122
4.2.2 BELARUS 123
4.2.3 IRAN 124
4.2.4 IRAQ 125
4.2.5 SERBIA 126
4.2.6 AZERBAIJAN 127
4.2.7 ALGERIA 128
4.2.8 TUNISIA 129
4.2.9 MOROCCO 130
4.2.10 EGYPT 131
4.2.11 NIGERIA 132
4.2.12 KENYA 133
4.2.13 UKRAINE 134
4.2.14 UZBEKISTAN 135
4.2.15 PAKISTAN 136
4.2.16 BOSNIA AND HERZEGOVINA 137
4.3 THORACIC AORTIC ANEURYSM (TAA) 138
4.3.1 REALISTIC SCENARIO 138
4.3.2 PESSIMISTIC SCENARIO 138
4.3.3 OPPORTUNISTIC SCENARIO 138
4.4 EUROPE, ASIA, AND MIDDLE EAST & AFRICA: THORACIC AORTIC ANEURYSM (TAA) MARKET: COUNTRY
LEVEL ANALYSIS 142
4.4.1 ROMANIA 142
4.4.2 BELARUS 143
4.4.3 IRAN 144
4.4.4 IRAQ 145
4.4.5 SERBIA 146
4.4.6 AZERBAIJAN 147
4.4.7 ALGERIA 148
4.4.8 TUNISIA 149
4.4.9 MOROCCO 150
4.4.10 EGYPT 151
4.4.11 NIGERIA 152
4.4.12 KENYA 153
4.4.13 UKRAINE 154
4.4.14 UZBEKISTAN 155
4.4.15 PAKISTAN 156
4.4.16 BOSNIA AND HERZEGOVINA 157
4.5 PERIPHERAL ARTERY DISEASE (PAD) OVERVIEW 158
4.5.1 REALISTIC SCENARIO 158
4.5.2 PESSIMISTIC SCENARIO 158
4.5.3 OPTIMISTIC SCENARIO 158
4.6 VASCULAR GRAFT MARKET, OVERVIEW 162
4.6.1 REALISTIC SCENARIO 162
4.6.2 OPTIMISTIC SCENARIO 162
4.6.3 PESSIMISTIC SCENARIO 163
4.7 EUROPE, ASIA, AND MIDDLE EAST & AFRICA: COUNTRY LEVEL ANALYSIS 164
4.7.1 ROMANIA 164
4.7.2 BELARUS 166
4.7.3 IRAN 168
4.7.4 IRAQ 169
4.7.5 SERBIA 171
4.7.6 AZERBAIJAN 173
4.7.7 ALGERIA 174
4.7.8 TUNISIA 176
4.7.9 MOROCCO 178
4.7.10 EGYPT 179
4.7.11 NIGERIA 181
4.7.12 KENYA 183
4.7.13 UKRAINE 184
4.7.14 UZBEKISTAN 186
4.7.15 PAKISTAN 188
4.7.16 BOSNIA AND HERZEGOVINA 189
4.8 PATENT FORAMEN OVALE (PFO) 191
4.8.1 REALISTIC SCENARIO 191
4.8.2 OPPORTUNISTIC SCENARIO 191
4.8.3 PESSIMISTIC SCENARIO 192
4.9 EUROPE, ASIA, AND MIDDLE EAST & AFRICA: PATENT FORAMEN OVALE (PFO) MARKET COUNTRY LEVEL ANALYSIS 193
4.9.1 ROMANIA 193
4.9.2 BELARUS 194
4.9.3 IRAN 194
4.9.4 IRAQ 194
4.9.5 SERBIA 195
4.9.6 AZERBAIJAN 195
4.9.7 ALGERIA 195
4.9.8 TUNISIA 196
4.9.9 MOROCCO 196
4.9.10 EGYPT 197
4.9.11 NIGERIA 197
4.9.12 KENYA 198
4.9.13 UKRAINE 198
4.9.14 UZBEKISTAN 199
4.9.15 PAKISTAN 199
4.9.16 BOSNIA AND HERZEGOVINA 200
4.10 ATRIAL SEPTAL DEFECT (ASD) 200
4.10.1 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR ATRIAL SEPTAL DEFECT (ASD), BY END USER: COUNTRY LEVEL ANALYSIS 202
4.10.1.1 ROMANIA 202
4.10.1.2 BELARUS 202
4.10.1.3 IRAN 203
4.10.1.4 IRAQ 203
4.10.1.5 SERBIA 204
4.10.1.6 AZERBAIJAN 204
4.10.1.7 ALGERIA 205
4.10.1.8 TUNISIA 205
4.10.1.9 MOROCCO 206
4.10.1.10 EGYPT 206
4.10.1.11 NIGERIA 207
4.10.1.12 KENYA 207
4.10.1.13 UKRAINE 208
4.10.1.14 UZBEKISTAN 208
4.10.1.15 PAKISTAN 209
4.10.1.16 BOSNIA AND HERZEGOVINA 209
5 BARIATRIC SURGERY: MARKET ANALYSIS 210
5.1 OVERVIEW 210
5.2 SLEEVE GASTRECTOMY MARKET OVERVIEW 211
5.2.1 MARKET SIZE AND FORECAST 211
5.2.1.1 REALISTIC SCENARIO 211
5.2.2 SLEEVE GASTRECTOMY MARKET GROWTH MODEL 211
5.2.2.1 PESSIMISTIC SCENARIO 211
5.2.2.2 OPPORTUNISTIC SCENARIO 212
5.2.3 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR SLEEVE GASTRECTOMY, BY END USER: COUNTRY LEVEL ANALYSIS 214
5.2.3.1 ROMANIA 214
5.2.3.2 BELARUS 215
5.2.3.3 IRAN 215
5.2.3.4 IRAQ 215
5.2.3.5 SERBIA 216
5.2.3.6 AZERBAIJAN 216
5.2.3.7 ALGERIA 217
5.2.3.8 TUNISIA 217
5.2.3.9 MOROCCO 217
5.2.3.10 EGYPT 218
5.2.3.11 NIGERIA 218
5.2.3.12 KENYA 218
5.2.3.13 UZBEKISTAN 219
5.2.3.14 PAKISTAN 219
5.2.3.15 UKRAINE 219
5.2.3.16 BOSNIA AND HERZEGOVINA 220
5.3 ROUX EN Y GASTRIC BYPASS (RYGB) OVERVIEW 220
5.3.1 MARKET SIZE AND FORECAST 220
5.3.1.1 REALISTIC SCENARIO 220
5.3.2 ROUX EN Y GASTRIC BYPASS (RYGB) GROWTH MODEL 221
5.3.2.1 PESSIMISTIC SCENARIO 221
5.3.2.2 OPPORTUNISTIC SCENARIO 221
5.3.3 EUROPE, ASIA, AND MIDDLE EAST & AFRICA FOR ROUX EN Y GASTRIC BYPASS (RYGB): COUNTRY LEVEL ANALYSIS 223
5.3.3.1 ROMANIA 223
5.3.3.2 BELARUS 224
5.3.3.3 IRAN 224
5.3.3.4 IRAQ 224
5.3.3.5 SERBIA 225
5.3.3.6 AZERBAIJAN 225
5.3.3.7 ALGERIA 225
5.3.3.8 TUNISIA 226
5.3.3.9 MOROCCO 226
5.3.3.10 EGYPT 226
5.3.3.11 NIGERIA 227
5.3.3.12 KENYA 227
5.3.3.13 UZBEKISTAN 227
5.3.3.14 PAKISTAN 228
5.3.3.15 UKRAINE 228
5.3.3.16 BOSNIA AND HERZEGOVINA 228
5.4 BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT) 229
5.4.1 MARKET SIZE AND FORECAST 229
5.4.1.1 REALISTIC SCENARIO 229
5.4.2 BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT) GROWTH MODEL 229
5.4.2.1 PESSIMISTIC SCENARIO 229
5.4.2.2 OPPORTUNISTIC SCENARIO 230
5.4.3 EUROPE, ASIA, AND MIDDLE EAST & AFRICA FOR BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT): COUNTRY LEVEL ANALYSIS 232
5.4.3.1 ROMANIA 232
5.4.3.2 BELARUS 233
5.4.3.3 IRAN 233
5.4.3.4 IRAQ 233
5.4.3.5 SERBIA 234
5.4.3.6 AZERBAIJAN 234
5.4.3.7 ALGERIA 234
5.4.3.8 TUNISIA 235
5.4.3.9 MOROCCO 235
5.4.3.10 EGYPT 235
5.4.3.11 NIGERIA 236
5.4.3.12 KENYA 236
5.4.3.13 UZBEKISTAN 236
5.4.3.14 PAKISTAN 237
5.4.3.15 UKRAINE 237
5.4.3.16 BOSNIA AND HERZEGOVINA 237
6 HERNIA REPAIR SURGERY: MARKET ANALYSIS 238
6.1 OVERVIEW 238
6.2 HERNIA REPAIR SURGERY MARKET, BY HERNIA TYPE, 2018-2030 (USD MILLION) 238
6.2.1 VENTRAL HERNIA + INCISIONAL HERNIA (BOTH OPEN AND LAPAROSCOPIC SURGERY) 239
6.2.1.1 REALISTIC SCENARIO 239
6.2.2 VENTRAL HERNIA + INCISIONAL HERNIA (BOTH OPEN AND LAPAROSCOPIC SURGERY) MARKET GROWTH MODEL 240
6.2.2.1 PESSIMISTIC SCENARIO 240
6.2.2.2 OPPORTUNISTIC SCENARIO 240
6.2.3 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR VENTRAL HERNIA + INCISIONAL HERNIA (BOTH OPEN AND LAPAROSCOPIC SURGERY), BY END USER: COUNTRY LEVEL ANALYSIS 243
6.2.3.1 ROMANIA 243
6.2.3.2 BELARUS 243
6.2.3.3 IRAN 244
6.2.3.4 IRAQ 244
6.2.3.5 SERBIA 244
6.2.3.6 AZERBAIJAN 245
6.2.3.7 ALJERIA 245
6.2.3.8 TUNISIA 246
6.2.3.9 MOROCCO 246
6.2.3.10 EGYPT 246
6.2.3.11 NIGERIA 247
6.2.3.12 KENYA 247
6.2.3.13 UKRAINE 247
6.2.3.14 UZBEKISTAN 248
6.2.3.15 PAKISTAN 248
6.2.3.16 BOSNIA AND HERZEGOVINA 248
6.2.4 HIATAL HERNIA (LAPAROSCOPIC) 249
6.2.5 EUROPE, ASIA, AND MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR HIATAL HERNIA (LAPAROSCOPIC), 2018-2030 (USD MILLION) (REALISTIC) 249
6.2.5.1 REALISTIC SCENARIO 249
6.2.6 HIATAL HERNIA (LAPAROSCOPIC) MARKET GROWTH MODEL 249
6.2.6.1 PESSIMISTIC SCENARIO 249
6.2.6.2 OPPORTUNISTIC SCENARIO 250
6.2.7 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR HIATAL HERNIA, BY END USER: COUNTRY LEVEL ANALYSIS 252
6.2.7.1 ROMANIA 252
6.2.7.2 BELARUS 252
6.2.7.3 IRAN 252
6.2.7.4 IRAQ 253
6.2.7.5 SERBIA 253
6.2.7.6 AZERBAIJAN 253
6.2.7.7 ALGERIA 254
6.2.7.8 TUNISIA 254
6.2.7.9 MOROCCO 254
6.2.7.10 EGYPT 255
6.2.7.11 NIGERIA 255
6.2.7.12 KENYA 255
6.2.7.13 UKRAINE 256
6.2.7.14 UZBEKISTAN 256
6.2.7.15 PAKISTAN 256
6.2.7.16 BOSNIA AND HERZEGOVINA 257
6.3 HERNIA REPAIR SURGERY MARKET, BY PRODUCT, 2018-2030 (USD MILLION) 257
6.3.1 PERMANENT SYNTHETIC MESH 258
6.3.1.1 REALISTIC SCNEARIO 258
6.3.2 PERMANENT SYNTHETIC MESH MARKET GROWTH MODEL 258
6.3.2.1 PESSIMISTIC SCENARIO 258
6.3.2.2 OPPORTUNISTIC SCENARIO 259
6.3.3 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR PERMANENT SYNTHETIC MESH, BY END USER: COUNTRY LEVEL ANALYSIS 260
6.3.3.1 ROMANIA 260
6.3.3.2 BELARUS 260
6.3.3.3 IRAN 261
6.3.3.4 IRAQ 261
6.3.3.5 SERBIA 261
6.3.3.6 AZERBAIJAN 262
6.3.3.7 ALGERIA 262
6.3.3.8 TUNISIA 262
6.3.3.9 MOROCCO 263
6.3.3.10 EGYPT 263
6.3.3.11 NIGERIA 263
6.3.3.12 KENYA 264
6.3.3.13 UKRAINE 264
6.3.3.14 UZBEKISTAN 264
6.3.3.15 PAKISTAN 265
6.3.3.16 BOSNIA AND HERZEGOVINA 265
6.3.4 INTRAPERITONEAL MESH 266
6.3.4.1 REALISTIC SCENARIO 266
6.3.5 INTRAPERITONEAL MESH MARKET GROWTH MODEL 266
6.3.5.1 PESSIMISTIC SCENARIO 266
6.3.5.2 OPPORTUNISTIC SCENARIO 267
6.3.6 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR INTRAPERITONEAL MESH, BY END USER: COUNTRY LEVEL ANALYSIS 268
6.3.6.1 ROMANIA 268
6.3.6.2 BELARUS 268
6.3.6.3 IRAN 269
6.3.6.4 IRAQ 269
6.3.6.5 SERBIA 269
6.3.6.6 AZERBAIJAN 270
6.3.6.7 ALGERIA 270
6.3.6.8 TUNISIA 270
6.3.6.9 MOROCCO 271
6.3.6.10 EGYPT 271
6.3.6.11 NIGERIA 271
6.3.6.12 KENYA 272
6.3.6.13 UKRAINE 272
6.3.6.14 UZBEKISTAN 272
6.3.6.15 PAKISTAN 273
6.3.6.16 BOSNIA AND HERZEGOVINA 273
6.4 BIO-ABSORBABLE MESH 274
6.4.1 REALISTIC SCENARIO 274
6.4.2 BIO-ABSORBABLE MESH MARKET GROWTH MODEL 274
6.4.2.1 PESSIMISTIC SCENARIO 274
6.4.2.2 OPPORTUNISTIC SCENARIO 275
6.4.3 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BIO-ABSORBABLE MESH, BY END USER: COUNTRY LEVEL ANALYSIS 276
6.4.3.1 ROMANIA 276
6.4.3.2 BELARUS 276
6.4.3.3 IRAN 277
6.4.3.4 IRAQ 277
6.4.3.5 SERBIA 277
6.4.3.6 AZERBAIJAN 278
6.4.3.7 ALGERIA 278
6.4.3.8 TUNISIA 278
6.4.3.9 MOROCCO 279
6.4.3.10 EGYPT 279
6.4.3.11 NIGERIA 279
6.4.3.12 KENYA 280
6.4.3.13 UKRAINE 280
6.4.3.14 UZBEKISTAN 280
6.4.3.15 PAKISTAN 281
6.4.3.16 BOSNIA AND HERZEGOVINA 281
6.4.4 BIOLOGIC MESH 282
6.4.4.1 REALISTIC SCENARIO 282
6.4.5 BIOLOGIC MESH MARKET GROWTH MODEL 282
6.4.5.1 PESSIMISTIC SCENARIO 282
6.4.5.2 OPPORTUNISTIC SCENARIO 283
6.4.6 EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET, FOR BIOLOGIC MESH, BY END USER: COUNTRY LEVEL ANALYSIS 284
6.4.6.1 ROMANIA 284
6.4.6.2 BELARUS 284
6.4.6.3 IRAN 285
6.4.6.4 IRAQ 285
6.4.6.5 SERBIA 285
6.4.6.6 AZERBAIJAN 286
6.4.6.7 ALGERIA 286
6.4.6.8 TUNISIA 286
6.4.6.9 MOROCCO 287
6.4.6.10 EGYPT 287
6.4.6.11 NIGERIA 287
6.4.6.12 KENYA 288
6.4.6.13 UKRAINE 288
6.4.6.14 UZBEKISTAN 288
6.4.6.15 PAKISTAN 289
6.4.6.16 BOSNIA AND HERZEGOVINA 289
7 ANALYSIS OF REIMBURSMENT AND REGULATORY LANDSCAPE 290
7.1 REIMBURSEMENT LANDSCAPE 290
7.1.1 GOVERNMENT MEDICARE PROGRAMS 290
7.1.2 PRIVATE MEDICAL INSURANCE SCENARIO 293
7.1.2.1 ROMANIA 293
7.1.2.2 BELARUS 293
7.1.2.3 IRAN 293
7.1.2.4 IRAQ 293
7.1.2.5 SERBIA 294
7.1.2.6 AZERBAIJAN 294
7.1.2.7 ALGERIA 294
7.1.2.8 TUNISIA 294
7.1.2.9 MOROCCO 294
7.1.2.10 EGYPT 294
7.1.2.11 NIGERIA 295
7.1.2.12 KENYA 295
7.1.2.13 UZBEKISTAN 295
7.1.2.14 PAKISTAN 295
7.1.2.15 BOSNIA AND HERZEGOVINA 296
7.1.3 DISEASE STATE REIMBURSEMENT 296
7.2 ANALYSIS OF REGULATORY LANDSCAPE BY COUNTRY 297
7.2.1 ROMANIA 297
7.2.2 BELARUS 298
7.2.3 IRAN 299
7.2.4 IRAQ 300
7.2.5 SERBIA 300
7.2.6 AZERBAIJAN 301
7.2.7 ALGERIA 301
7.2.8 TUNISIA 302
7.2.9 MOROCCO 303
7.2.10 EGYPT 304
7.2.11 NIGERIA 304
7.2.12 KENYA 305
7.2.13 UZBEKISTAN 306
7.2.14 PAKISTAN 307
7.2.15 UKRAINE 308
7.2.16 BOSNIA AND HERZEGOVINA 309
8 COMPETITIVE LANDSCAPE 311
8.1 MARKET SHARE ANALYSIS, EMEA MEDICAL DEVICE MARKET, 2021-2022 311
8.1.1 CLUSTER 1: EUROPE MARKET SHARE ANALYSIS, 2021-2022 (%) 311
8.1.2 CLUSTER 2: ASIA MARKET SHARE ANALYSIS, 2021-2022 (%) 312
8.1.3 CLUSTER 3: MEA MARKET SHARE ANALYSIS, 2021-2022 (%) 313
8.2 COMPETETIVE INSIGHTS BY COUNTRY 314
8.2.1.1 ROMANIA 314
8.2.1.2 BELARUS 314
8.2.1.3 IRAN 315
8.2.1.4 IRAQ 315
8.2.1.5 SERBIA 316
8.2.1.6 AZERBAIJAN 316
8.2.1.7 ALGERIA 317
8.2.1.8 TUNISIA 317
8.2.1.9 MOROCCO 318
8.2.1.10 EGYPT 318
8.2.1.11 NIGERIA 319
8.2.1.12 KENYA 319
8.2.1.13 UZBEKISTAN 320
8.2.1.14 PAKISTAN 320
8.2.1.15 UKRAINE 321
8.2.1.16 BOSNIA AND HERZEGOVINA 321
8.3 PRICING ANALYSIS, 2021-2022 322
8.3.1 ANEURYSM AND PAD PRODUCT PRICING ANALYSIS, 2021-2022 322
8.3.2 HERNIA REPAIR PRODUCT PRICING ANALYSIS, 2021-2022 322
8.3.3 TREATMENT/PROCEDURE: PRICING ANALYSIS, 2021-2022 323
8.4 FINANCIAL MATRIX ANALYSIS 324
8.5 MARKET PLAYERS BY COUNTRY 325
8.5.1 ROMANIA 325
8.5.2 BELARUS 325
8.5.3 IRAN 326
8.5.4 IRAQ 326
8.5.5 SERBIA 326
8.5.6 AZERBAIJAN 326
8.5.7 ALGERIA 327
8.5.8 TUNISIA 327
8.5.9 MOROCCO 327
8.5.10 EGYPT 328
8.5.11 NIGERIA 328
8.5.12 KENYA 328
8.5.13 UZBEKISTAN 329
8.5.14 PAKISTAN 329
8.5.15 UKRAINE 330
8.5.16 BOSNIA AND HERZEGOVINA 330
8.6 KEY DISTRIBUTORS BY COUNTRY 330
8.6.1 ROMANIA 330
8.6.2 BELARUS 331
8.6.3 IRAN 331
8.6.4 IRAQ 332
8.6.5 SERBIA 332
8.6.6 AZERBAIJAN 332
8.6.7 ALGERIA 333
8.6.8 TUNISIA 333
8.6.9 MOROCCO 333
8.6.10 EGYPT 333
8.6.11 NIGERIA 333
8.6.12 KENYA 334
8.6.13 UZBEKISTAN 334
8.6.14 PAKISTAN 334
8.6.15 UKRAINE 334
8.6.16 BOSNIA AND HERZEGOVINA 334
8.7 KEY DEVELOPMENTS IN THE EUROPE, ASIA, MIDDLE EAST & AFRICA MEDICAL DEVICES MARKET 335
9 REMARKS AND CONCLUSIONS 338
9.1.1 COUNTRY WISE MARKET OPPORTUNITY ANALYSIS 338
9.1.2 PAD MARKET ANALYSIS 339
9.1.3 AAA MARKET ANALYSIS 340
9.1.4 TAA MARKET ANALYSIS 341
9.1.5 PFO AND ASD MARKET ANALYSIS 342
9.1.6 SURGERY MARKET ANALYSIS 343
10 APPENDIX 344
10.1 GLOSSARY 344
10.1.1 ABDOMINAL AORTIC ANEURYSM (AAA) 344
10.1.1.1 INFRARENAL AAA 344
10.1.1.2 PARARENAL AAA 344
10.1.1.3 ENDOVASCULAR STENT GRAFT 344
10.1.2 THORACIC AORTIC ANEURYSM (TAA) 344
10.1.3 PAD 344
10.1.3.1 PERIPHERAL ARTERY DISEASE (PAD) 344
10.1.3.1.1 BALLOON CATHETERS 344
10.1.3.1.2 PLAQUE MODIFICATION DEVICES 344
10.1.3.1.3 ANGIOPLASTY STENTS 345
10.1.3.1.4 BARE METAL STENTS 345
10.1.3.1.5 DRUG-ELUTING STENTS 345
10.1.3.1.6 INFERIOR VENA CAVA FILTERS 345
10.1.3.2 BALLOON ANGIOPLASTY 345
10.1.4 PATENT FORAMEN OVALE (PFO) 345
10.1.5 ATRIAL SEPTAL DEFECT (ASD) 345
10.1.6 BARIATRIC AND HERNIA SURGERY 345
10.1.6.1 BARIATRIC SURGERY 345
10.1.6.1.1 SLEEVE GASTRECTOMY 345
10.1.6.1.2 ROUX-EN-Y GASTRIC BYPASS (RYGB) 345
10.1.6.1.3 BUTTRESSING DEVICE (STAPLE LINE REINFORCEMENT) 346
10.1.6.2 HERNIA REPAIR SURGERY 346
10.1.6.2.1 VENTRAL HERNIA 346
10.1.6.2.2 HIATAL HERNIA 346
10.1.6.3 HERNIA MESH 346
10.1.6.3.1 PERMANENT SYNTHETIC MESH 346
10.1.6.3.2 INTRAPERITONEAL MESH 346
10.2 LIST OF ASSUMPTIONS 347
10.3 RESEARCH METHODOLOGY 347
10.3.1 PURCHASED DATABASE: 347
10.3.2 MRFRS INTERNAL DATABASE 348
10.3.3 SECONDARY SOURCES: 348
10.3.4 MAKE THIRD PARTY PERSPECTIVE: 348
10.3.4.1 PRIMARY RESEARCH 348
10.3.4.2 INTERVIEW SCOPE: 350
10.3.4.3 SAMPLE SIZE FOR THE STUDY: 350
10.3.5 DATA ANALYSIS 350
10.3.5.1 DATA ANALYSIS MARKET FORMULATION: 351
10.3.6 RESOURCE ALLOCATION & COST STRUCTURE 356
10.4 REFERENCES 357
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security